Creative Bioarray

Creative Bioarray is a contract research organization specializing in preclinical drug development services. The company offers integrated solutions spanning compound screening, safety evaluation, and regulatory-aligned study designs to support IND submission timelines.

Service Capabilities:

• Drug screening and compound evaluation
• ADME-PK (absorption, distribution, metabolism, excretion and pharmacokinetics) profiling
• In vitro and in vivo toxicity studies
• Cell biology and molecular biology services
• Disease-specific models across oncology, neurology, cardiovascular, and metabolic therapeutic areas
• Ion channel screening (cardiac, neurological applications)
• Cardiomyocyte and neuronal functional assays
• Animal behavior and cognitive function testing
• Electrophysiological recordings and telemetric monitoring

Product Portfolio: Creative Bioarray also supplies research-grade biological materials including 2,000+ primary cell lines (17 species), 1,500+ tumor cell lines, stem cells, biosamples, ISH/FISH probes, stains and dyes, and ADME kits. The company manufactures cell culture media, cytokines, and cell therapy products (SuperEXP® system) in compliance with ISO 13485 and ISO 9001.

Therapeutic Focus: The organization serves small molecules, antibodies, oligonucleotides, cell and gene therapies, peptides, proteins, and vaccines across pharmaceutical, biopharma, medical device, nutraceutical, and cosmetic industries.